BioGaia AB (publ) (FRA:BGLA)
Germany flag Germany · Delayed Price · Currency is EUR
9.34
+0.08 (0.86%)
Last updated: May 13, 2025

BioGaia AB Statistics

Total Valuation

BioGaia AB has a market cap or net worth of EUR 987.88 million. The enterprise value is 873.00 million.

Market Cap 987.88M
Enterprise Value 873.00M

Important Dates

The next estimated earnings date is Friday, July 18, 2025.

Earnings Date Jul 18, 2025
Ex-Dividend Date May 8, 2025

Share Statistics

Current Share Class 97.46M
Shares Outstanding n/a
Shares Change (YoY) +0.13%
Shares Change (QoQ) n/a
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 77.73M

Valuation Ratios

The trailing PE ratio is 34.60.

PE Ratio 34.60
Forward PE n/a
PS Ratio 7.55
PB Ratio 6.02
P/TBV Ratio 6.62
P/FCF Ratio 30.50
P/OCF Ratio 30.02
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 21.55, with an EV/FCF ratio of 26.96.

EV / Earnings 30.58
EV / Sales 6.69
EV / EBITDA 21.55
EV / EBIT 22.91
EV / FCF 26.96

Financial Position

The company has a current ratio of 10.84

Current Ratio 10.84
Quick Ratio 8.31
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage 206.82

Financial Efficiency

Return on equity (ROE) is 15.69% and return on invested capital (ROIC) is 13.13%.

Return on Equity (ROE) 15.69%
Return on Assets (ROA) 11.48%
Return on Invested Capital (ROIC) 13.13%
Return on Capital Employed (ROCE) 22.02%
Revenue Per Employee 581,372
Profits Per Employee 126,885
Employee Count 225
Asset Turnover 0.63
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -11.85% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -11.85%
50-Day Moving Average 9.83
200-Day Moving Average 9.92
Relative Strength Index (RSI) 48.11
Average Volume (20 Days) 32

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, BioGaia AB had revenue of EUR 130.81 million and earned 28.55 million in profits. Earnings per share was 0.28.

Revenue 130.81M
Gross Profit 95.24M
Operating Income 38.20M
Pretax Income 36.51M
Net Income 28.55M
EBITDA 39.78M
EBIT 38.20M
Earnings Per Share (EPS) 0.28
Full Income Statement

Balance Sheet

The company has 115.15 million in cash and n/a in debt, giving a net cash position of 115.15 million.

Cash & Cash Equivalents 115.15M
Total Debt n/a
Net Cash 115.15M
Net Cash Per Share n/a
Equity (Book Value) 163.98M
Book Value Per Share 1.62
Working Capital 136.31M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 32.91 million and capital expenditures -521,875, giving a free cash flow of 32.38 million.

Operating Cash Flow 32.91M
Capital Expenditures -521,875
Free Cash Flow 32.38M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 72.81%, with operating and profit margins of 29.20% and 21.83%.

Gross Margin 72.81%
Operating Margin 29.20%
Pretax Margin 27.91%
Profit Margin 21.83%
EBITDA Margin 30.41%
EBIT Margin 29.20%
FCF Margin 24.76%

Dividends & Yields

This stock pays an annual dividend of 0.63, which amounts to a dividend yield of 6.85%.

Dividend Per Share 0.63
Dividend Yield 6.85%
Dividend Growth (YoY) 6.92%
Years of Dividend Growth 1
Payout Ratio 61.94%
Buyback Yield -0.13%
Shareholder Yield 6.72%
Earnings Yield 2.89%
FCF Yield 3.28%
Dividend Details

Stock Splits

The last stock split was on May 18, 2022. It was a forward split with a ratio of 5.

Last Split Date May 18, 2022
Split Type Forward
Split Ratio 5

Scores

Altman Z-Score n/a
Piotroski F-Score n/a